CFL1 and breast cancer: This can be achieved through an immunohistochemical classification of receptor pathways involved in breast cancer, such as NF‐κβ, cofilin, Hedgehog, Akt, Wnt, PI3K‐Akt, PI3K‐Akt–mTOR, and PI3K [37, 38, 39].